LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Truvian Sciences raises $105M in oversubscribed Series C financing
Funds from the round will be put towards accelerating FDA submission and commercialization for the company’s compact and fully automated benchtop system. The technology is being developed to provide healthcare providers with lab-quality results from a small sample of blood. In addition, the platform is intended to be an affordable diagnostic solution compared to the alternative - off-site labs. To-date, the company has more than $150M. Some of the leading strategics in the diagnostic testing market include BD, Illumina, and Roche.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Hyperfine raises $90M in Series D Financing
Hyperfine is the company behind Swoop, an FDA 510(k)-cleared portable MRI machine. Funds from the round will be utilized to accelerate the company’s plans for commercial launch in multiple countries, as well as to aggressively improve the commercial expansion of their technology in the US. In addition to the support of commercialization efforts, the funds will be used to obtain new regulatory clearances, expand uses cases, and improve their technology’s deep learning and AI capabilities. Key strategics in the MRI market include Canon, GE Healthcare, and Siemens.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
MIVI Neuroscience – next-generation solutions for neurointervention
MIVI is currently developing the DAISe Clot Retrieval System, a catheter deployed solution intended to facilitate clot retrieval. The device uses unique materials that are vessel conforming and prevent mechanical backstop. In addition to the DAISe system, the company is developing the Q Aspiration System. In January 2021, the company closed a Series B round of $35M. The funds from the round will be used fund clinical trials and subsequent commercialization of the two products. Penumbra, Stryker, and Terumo are leading competitors in the market for neurointerventional devices.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Resmonics is developing a digital biomarker service for patients with asthma and COPD
Asthma Guardian is the company’s first product. The smartphone application monitors a patient’s breathing in real-time for signs of future exacerbations. The company recently closed a pre-seed financing round. Funds from the round will be used to accelerate market entry for the company’s digital health application, which is anticipated to reach European markets in Q3/21.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Noctrix Health raises $17M from Series B round
Noctrix Health is developing wearable therapeutics for the management of chronic illnesses. The company was founded to develop a non-pharmaceutical treatment for restless leg syndrome (RLS). Using a neuromodulation-based approach to treat the painful sensations associated with RLS. The device has received “Breakthrough Device Designation” from the US FDA. Boston Scientific, Medtronic, and Nevro are some of the key strategics in the neuromodulation devices market.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Cimon Medical is developing ultrasound technology for continuous blood flow monitoring
The company’s first product, NeoDoppler, is being developed to monitor and reduce the risk of neurodevelopmental damage in neonates. The company is currently working with manufacturing partners to achieve a launch in Q4 2021. In December 2020, Cimon Medical raised $7M in capital from a Series A round. Key strategics in the ultrasound market include GE Healthcare, Philips, and Siemens.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Occuity is developing non-contact diagnostic devices for disease screening and monitoring
The company’s intellectual property is being used to develop handheld pachymeters, keratometers, and pupillometers for use in human and veterinary optometry. According to Occuity, the device will be released in 2021. In October 2020, the company raised $1.3M in a Seed round. Alcon, Carl Zeiss, and Nidek are key strategics currently competing in the ophthalmology market.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Neuros Medical is raising $42.8M in equity
Currently the company has completed the sale of $37M in equity from 24 investors. Neuros Medical is a developer of proprietary neuromodulation technology for the treatment of chronic pain. Neuros’ Altius System uses an implantable generator to deliver electrical signals in the peripheral nervous system to block pain signals. Major competitors in the neuromodulation market include Abbott, Boston Scientific, and LivaNova.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Venari Medical completes $5.3M Seed round
The company is developing BioVena, a catheter-based therapy for chronic venous disease. BioVena disrupts the inner vessel lining, which causes natural scarring and vessel closure that diverts blood away from the diseased vessels. Abbott, Boston Scientific, and Edwards are some of the key strategics in the competitive landscape.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update
LSI's Medtech Startup Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.
Diality – bringing dialysis into the patient’s home
Diality is developing a portable home hemodialysis machine intended to help improve the quality of life of patient’s with kidney disease. The company’s product is currently pending CE Mark in the EU and FDA clearance in the US. Diality has raised $30.5M in capital as of October 2020. Key strategics in the hemodialysis market include Baxter, Fresenius, and Nipro.
Start a Free Trial to Medtech Startup Tracker Today
Read More
Topics:
Insider,
Startup,
Strategics,
Medtech,
Medtech Venture Capital,
Medtech Innovation Weekly Update